The agreement would facilitate providing Tevogen Bio with in-house cell therapy production capabilities Formalized agreement aligns with previously announced topline forecastsWARREN, N.J., April 17, 2025 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced it has entered into an agreement with CD 8 Technology Services LLC (“CD8”) for the development and/or acquisition of a turn-key facility that is intended to support both in-house pre-clinical research and GMP cell therapy production capabilities. Tevogen Bio will provide the primary staff and operations for the facility, which is a key component of the company’s long-term strategy to accelerate development timelines, maintain operational agility, and control cost. Tevogen Bio believes that this agreement should allow the...

100% ownership of Easy Modular Manufacturing subsidiary strengthens operational platform as DUTV prepares for accelerating commercial execution and expanded market activity MANKATO, Minn., April 17, 2025 (GLOBE NEWSWIRE) — Digital Utilities Ventures, Inc. (OTC: DUTV), a leader in regenerative agriculture and clean water technologies, today announced it now holds 100% ownership of its previously majority-owned subsidiary, Easy Modular Manufacturing, Inc. “As DUTV prepares for a new phase of commercialization and investor engagement, achieving full ownership of Easy Modular Manufacturing helps ensure that the value created from our manufacturing operations accrues entirely to our shareholders,” said Mark K. Gaalswyk, CEO of DUTV. “This move strengthens the foundation we’ve built and positions us to better scale production in response...

BOLLORÉ PRESS RELEASE April 17, 2025 On September 13, 2024, Bolloré SE had filed three alternative buyout offers followed by mandatory squeeze-outs on the shares of Compagnie du Cambodge, Financière Moncey, and Société Industrielle et Financière de l’Artois (SIF Artois). As compared to the 1-month VWAP of the target companies prior to the announcement of the tender offers, the cash offer, pursuant to the price increase decided on December 23, 2024, represented the following premiums:50.5% for Compagnie du Cambodge shares; 61.8% for Financière Moncey shares; 95.3% for SIF Artois shares.The exchange offer, whose ratio was also increased on December 23, 2024, offered shareholders of the three target companies an opportunity rarely granted in such a context , enabling them to convert their investment into UMG NV shares under favorable...

BOLLORÉ PRESS RELEASE April 17, 2025 On September 13, 2024, Bolloré SE had filed three alternative buyout offers followed by mandatory squeeze-outs on the shares of Compagnie du Cambodge, Financière Moncey, and Société Industrielle et Financière de l’Artois (SIF Artois). As compared to the 1-month VWAP of the target companies prior to the announcement of the tender offers, the cash offer, pursuant to the price increase decided on December 23, 2024, represented the following premiums:50.5% for Compagnie du Cambodge shares; 61.8% for Financière Moncey shares; 95.3% for SIF Artois shares.The exchange offer, whose ratio was also increased on December 23, 2024, offered shareholders of the three target companies an opportunity rarely granted in such a context , enabling them to convert their investment into UMG NV shares under favorable...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree SCIENCE IN SPORT PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ALLIANCE PHARMA PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Life Science REIT Plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening position...

Deal Allows VERB’s MARKET.live To Democratize Social Commerce, Offering Brands and Merchants An AI Powered Omnichannel Livestream Shopping Experience With Full Control Over Audience, Content, And Conversions LAS VEGAS and LOS ALAMITOS, Calif., April 17, 2025 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the ”Company”), Transforming the Landscape of Social Commerce, Social Telehealth and Social Crowdfunding with MARKET.live; VANITYPrescribed; GoodGirlRx; and the GO FUND YOURSELF TV Show, today announces that the Company, Lyvecom, Inc. (“Lyvecom”) and the shareholders of Lyvecom entered into a definitive Stock Purchase Agreement dated April 11, 2025 (the “Purchase Agreement”) to acquire all of the outstanding capital stock of Lyvecom (the “Acquisition”). The Acquisition closed on April 11, 2025. The purchase...

Acquisition Delivers Multi-Million-Dollar Sales Pipeline and Significant Working Capital Without an Equity Raise or Dilution Omaha, NE, April 17, 2025 (GLOBE NEWSWIRE) — CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or the “Company”), developer of patented technology that works as a safe and low-cost replacement for traditional cleaning chemicals, today announced the successful completion of its acquisition of Sanzonate Europe Ltd. (“Sanzonate”), the largest distributor of aqueous ozone cleaning technologies in Europe. This strategic acquisition strengthens CleanCore’s European market presence, enhances financial performance, and unlocks a multi-million-dollar sales pipeline. The Company expects the transaction to drive immediate revenue growth, bolster profitability, and accelerate its expansion into global markets,...